Mélanie Bézard

509 total citations
19 papers, 147 citations indexed

About

Mélanie Bézard is a scholar working on Molecular Biology, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mélanie Bézard has authored 19 papers receiving a total of 147 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Nephrology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mélanie Bézard's work include Amyloidosis: Diagnosis, Treatment, Outcomes (16 papers), Parathyroid Disorders and Treatments (7 papers) and Peptidase Inhibition and Analysis (3 papers). Mélanie Bézard is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (16 papers), Parathyroid Disorders and Treatments (7 papers) and Peptidase Inhibition and Analysis (3 papers). Mélanie Bézard collaborates with scholars based in France, United States and Romania. Mélanie Bézard's co-authors include Thibaud Damy, Mounira Kharoubi, Silvia Oghina, Diane Bodez, Alain Cohen‐Solal, Wulfran Bougouin, Michel Komajda, Alexandre Mebazaa, Arnault Galat and Amira Zaroui and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Mélanie Bézard

16 papers receiving 142 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mélanie Bézard France 7 100 56 49 23 18 19 147
Marianna Fontana United Kingdom 5 94 0.9× 17 0.3× 47 1.0× 23 1.0× 14 0.8× 15 108
Cristiane Carvalho Singulane United States 7 50 0.5× 43 0.8× 24 0.5× 12 0.5× 16 0.9× 21 107
Guerino Giuseppe Varrà Italy 5 77 0.8× 26 0.5× 42 0.9× 26 1.1× 14 0.8× 8 93
Muhammad U. Rauf United Kingdom 7 115 1.1× 18 0.3× 60 1.2× 26 1.1× 22 1.2× 14 126
Giulia Saturi Italy 5 51 0.5× 84 1.5× 17 0.3× 17 0.7× 15 0.8× 13 125
Jeffeny De Los Santos United States 8 211 2.1× 78 1.4× 104 2.1× 69 3.0× 29 1.6× 22 234
Giulio Sinigiani Italy 6 85 0.8× 27 0.5× 32 0.7× 21 0.9× 13 0.7× 18 98
Miguel Ángel Aibar Arregui Spain 7 59 0.6× 20 0.4× 25 0.5× 23 1.0× 11 0.6× 26 113
Evan Watts United States 4 43 0.4× 24 0.4× 27 0.6× 12 0.5× 8 0.4× 6 107
Fernando de Frutos Spain 7 64 0.6× 142 2.5× 15 0.3× 11 0.5× 6 0.3× 23 208

Countries citing papers authored by Mélanie Bézard

Since Specialization
Citations

This map shows the geographic impact of Mélanie Bézard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélanie Bézard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélanie Bézard more than expected).

Fields of papers citing papers by Mélanie Bézard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mélanie Bézard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélanie Bézard. The network helps show where Mélanie Bézard may publish in the future.

Co-authorship network of co-authors of Mélanie Bézard

This figure shows the co-authorship network connecting the top 25 collaborators of Mélanie Bézard. A scholar is included among the top collaborators of Mélanie Bézard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélanie Bézard. Mélanie Bézard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Zaroui, Amira, Charlotte Lafont, Mounira Kharoubi, et al.. (2025). Men and women differ with regard to the prevalence, phenotype, and prognosis of wild-type transthyretin amyloid cardiomyopathy. Amyloid. 32(3). 255–266.
3.
Zaroui, Amira, Mounira Kharoubi, Mélanie Bézard, et al.. (2024). A phenotypic comparison of the Romanian and French ATTRv cohorts: Glu54Gln founder pathogenic variant vs the most common variants in Western Europe. International Journal of Cardiology. 419. 132714–132714. 1 indexed citations
4.
Annabi, Mohamed‐Salah, Rasmus Carter‐Storch, Amira Zaroui, et al.. (2024). Prevalence, Characteristics, and Impact on Prognosis of Aortic Stenosis in Patients With Cardiac Amyloidosis. Journal of the American Heart Association. 13(13). e034723–e034723. 2 indexed citations
5.
Bézard, Mélanie, Amira Zaroui, Mounira Kharoubi, et al.. (2024). Internalisation of immunoglobulin light chains by cardiomyocytes in AL amyloidosis: what can biopsies tell us?. Amyloid. 31(3). 209–219. 1 indexed citations
6.
7.
Beldi‐Ferchiou, Asma, Vincent Audard, François Lemonnier, et al.. (2022). Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis. SHILAP Revista de lepidopterología. 3(3). 828–837. 3 indexed citations
8.
Bézard, Mélanie, Mounira Kharoubi, Arnault Galat, et al.. (2022). Real-Life Evaluation of an Algorithm for the Diagnosis of Cardiac Amyloidosis. Mayo Clinic Proceedings. 98(1). 48–59. 3 indexed citations
9.
Bézard, Mélanie, Stéphane Moutereau, Mounira Kharoubi, et al.. (2022). Prevalence and Determinants of Iron Deficiency in Cardiac Amyloidosis. ESC Heart Failure. 9(2). 1314–1327. 9 indexed citations
10.
Oghina, Silvia, Wulfran Bougouin, Mounira Kharoubi, et al.. (2021). Echocardiographic Patterns of Left Ventricular Diastolic Function in Cardiac Amyloidosis: An Updated Evaluation. Journal of Clinical Medicine. 10(21). 4888–4888. 6 indexed citations
11.
Bézard, Mélanie, Silvia Oghina, Damien Vitiello, et al.. (2021). Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement. PLoS ONE. 16(9). e0257189–e0257189. 8 indexed citations
12.
Oghina, Silvia, Wulfran Bougouin, Mélanie Bézard, et al.. (2021). The Impact of Patients With Cardiac Amyloidosis in HFpEF Trials. JACC Heart Failure. 9(3). 169–178. 52 indexed citations
13.
Kharoubi, Mounira, Mélanie Bézard, Silvia Oghina, et al.. (2021). Assessing Cardiac Amyloidosis Subtypes by Unsupervised Phenotype Clustering Analysis. Journal of the American College of Cardiology. 78(22). 2177–2192. 9 indexed citations
14.
Oghina, Silvia, Constant Josse, Mélanie Bézard, et al.. (2021). Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide and High-Sensitivity Troponin T Levels in the Natural History of Transthyretin Amyloid Cardiomyopathy and Their Evolution after Tafamidis Treatment. Journal of Clinical Medicine. 10(21). 4868–4868. 25 indexed citations
15.
Kharoubi, Mounira, Frédéric Roche, Mélanie Bézard, et al.. (2020). Prevalence and Prognostic Value of Autonomic Neuropathy Assessed by Sudoscan® in Transthyretin Wild-Type Cardiac Amyloidosis. ESC Heart Failure. 8(2). 1656–1665. 12 indexed citations
16.
Pezel, Théo, Emmanuelle Berthelot, Jean Gauthier, et al.. (2020). Epidemiological characteristics and therapeutic management of patients with chronic heart failure who use smartphones: Potential impact of a dedicated smartphone application (report from the OFICSel study). Archives of cardiovascular diseases. 114(1). 51–58. 12 indexed citations
17.
Chong-Nguyen, C., Emmanuelle Berthelot, Florence Beauvais, et al.. (2018). Do heart failure women and men have the same clinical characteristics and benefit from the same care management?: TIME'S UP!!! A report from the OFICSel Study. Archives of Cardiovascular Diseases Supplements. 11(1). 44–44. 1 indexed citations
18.
Damy, Thibaud, Diane Bodez, Soulef Guendouz, et al.. (2018). Effect on mortality of combined or sequential chemotherapy in patients with cardiac light-chain amyloidosis. Archives of Cardiovascular Diseases Supplements. 11(1). 44–45. 1 indexed citations
19.
Bézard, Mélanie. (2002). Un troupeau ovin intoxiqué par le galéga officinal. 33(227). 66–67. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marianna Fontana Breakdown of academic impact, for papers by Cristiane Carvalho Singulane Breakdown of academic impact, for papers by Guerino Giuseppe Varrà Breakdown of academic impact, for papers by Muhammad U. Rauf Breakdown of academic impact, for papers by Giulia Saturi Breakdown of academic impact, for papers by Jeffeny De Los Santos Breakdown of academic impact, for papers by Giulio Sinigiani Breakdown of academic impact, for papers by Miguel Ángel Aibar Arregui Breakdown of academic impact, for papers by Evan Watts Breakdown of academic impact, for papers by Fernando de Frutos
Rankless by CCL
2026